Leaflet TEKCIS 2-50 GBQ radionuclide generator

Indicated for: diagnostic imaging

Route of administration: intravenous

Substance: Tc 99 m - pertecnetat (contrast agent)

ATC: V09FX01 (Various | Thyroid | Various thyroid diagnostic radiopharmaceuticals)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Tc-99m-pertechnetate is a radiopharmaceutical used in medical imaging to evaluate the thyroid gland, salivary glands, and other anatomical structures. It is commonly used in thyroid scans for the diagnosis of hyperthyroidism or thyroid nodules.

The medication is administered intravenously, and images are obtained using a gamma camera. It is important for patients to follow the doctor's instructions before and after the procedure.

Patients should be aware of potential adverse reactions, such as allergic reactions or discomfort at the injection site. It is important to inform the doctor of any unusual symptoms.

Side effects are rare but may include allergic reactions, nausea, or skin rashes. Patients should be informed of these risks before the procedure.

General data about TEKCIS 2-50 GBQ

  • Substance: Tc 99 m - pertecnetat
  • Date of latest medicines list: 01-05-2023
  • Product code: W69500005
  • Concentration: 2-50GBq
  • Pharmaceutical form: radionuclide generator
  • Quantity: 1
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: CIS BIO INTERNATIONAL - FRANTA
  • Holder: CIS BIO INTERNATIONAL - FRANTA
  • Number: 14931/2023/05
  • Shelf life: Generator: 21 de days de la data de fabricatie

Pharmaceutical forms available for Tc 99 m - pertecnetat

Concentrations available for Tc 99 m - pertecnetat

  • 10-40 GBQ
  • 2-50GBq
  • 2.08-41.58 GBq
  • 2.15-43GBq
  • 8.0-175GBq